Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ProPhase Labs, Inc. - Common Stock (NQ:PRPH)

0.1718 -0.0082 (-4.56%)
Streaming Delayed Price Updated: 12:37 PM EST, Nov 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ProPhase Labs, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Which stocks are moving after the closing bell on Friday? ↗
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
News headline image
Earnings Scheduled For November 13, 2024 ↗
 
Via Benzinga
News headline image
ProPhase Labs's Earnings: A Preview ↗
 
Via Benzinga
News headline image
S&P 500 Tops 6,000; Sezzle Shares Spike Higher ↗
 
Via Benzinga
Topics Stocks
News headline image
Dow Tops 44,000; US Consumer Sentiment Increases In November ↗
 
Via Benzinga
Topics Stocks
News headline image
ProPhase Labs's Earnings: A Preview ↗
 
Via Benzinga
News headline image
ProPhase Labs Earnings Preview ↗
 
Via Benzinga
News headline image
Analyst Expectations for ProPhase Labs's Future ↗
 
Via Benzinga
News headline image
Recap: ProPhase Labs Q1 Earnings ↗
 
Via Benzinga
News headline image
Why ProPhase Labs (PRPH) Stock Is Down 47% Today ↗
ProPhase Labs shares are trading lower by 50% during Friday's session. The company announced a 4.17 million share offering at 72 cents per share, totaling $3 million. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
US Stocks Mixed; Fluor Earnings Miss Views ↗
 
Via Benzinga
Topics Earnings
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Upstart Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Overview Of Value Stocks In The Healthcare Sector ↗
 
Via Benzinga
News headline image
Deal Dispatch: UFC, WWE Parent TKO Takes On Bull Riding; Endeavor Looks To Sell Tennis; Another Car Company Goes Bankrupt ↗
IMG tennis assets are on the auction block. The announcement came after TKO inked a deal with Endeavor for Professional Bull Riders. 
Via Benzinga
News headline image
PRPH Stock Earnings: ProPhase Labs Misses EPS, Misses Revenue for Q2 2024 ↗
PRPH stock results show that ProPhase Labs missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
PRPH Stock Earnings: ProPhase Labs Beats EPS, Misses Revenue for Q1 2024 ↗
PRPH stock results show that ProPhase Labs beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
PRPH Stock Earnings: ProPhase Labs Misses EPS, Misses Revenue for Q4 2023 ↗
PRPH stock results show that ProPhase Labs missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Earnings Scheduled For March 15, 2024 ↗
Companies Reporting Before The Bell • EHang Holdings (NASDAQ:EH) is expected to report quarterly loss at $0.10 per share on revenue of $7.83 million. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 99 stocks hit new 52-week lows. 
Via Benzinga
News headline image
DSS, Inc.'s (NYSE American: DSS) Subsidiary Appoints New Chief Investment Officer To Aggressively Develop Mutual Fund Business For Eventual Spinoff ↗
DSS Wealth, Inc. has appointed Daniel Lew as its new Chief Investment Officer (CIO) and Portfolio Manager. DSS Wealth is a mutual fund and a wholly-owned subsidiary of DSS, Inc. 
Via Benzinga
News headline image
DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement 
Via News Direct
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  During the Friday's sesion, 157 stocks hit new 52-week lows. 
Via Benzinga
DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
By David Willey, Benzinga 
Via TheNewswire.com
News headline image
DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement ↗
DSS, Inc. 
Via Benzinga
News headline image
Earnings Scheduled For August 10, 2023 ↗
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
7 Small-Cap Biotech Stocks with Massive Potential ↗
Although small-cap biotech stocks present high risks, if they hit one out of the park, the rewards can be astronomical. 
Via InvestorPlace
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.